US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eloxx Pharmaceuticals (Uplisting)

15.31

-0.1100-0.71%

Volume:14.33K

Turnover:217.31K

Market Cap:61.80M

PE:-5.37

High:15.71

Open:14.94

Low:14.42

Close:15.42

52wk High:23.40

52wk Low:0.0000

Shares:4.04M

Float Shares:2.39M

Volume Ratio:0.72

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8493

EPS(LYR):-5.3408

ROE:-615.23%

ROA:-97.59%

PB:1.33

PE(LYR):-2.87

Loading ...

Overview Company News Filings

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

Eloxx Pharmaceuticals initiated with a Buy at Guggenheim

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

NASDAQ Trade Halt Volatility Trading Pause at 11:17 Am

Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors

Eloxx Pharmaceuticals initial beneficial ownership filing names Domicilium Real Estate Fund III LP as 10% owner

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

Eloxx Pharmaceuticals files Form 3 for director Nina S. Kjellson, reporting no beneficial ownership

Eloxx Pharma shareholders back reverse stock split of up to 1-for-20

Eloxx Pharmaceuticals Inc - Applies to List Common Stock on Nasdaq Under Symbol Elox - SEC Filing

THOMSON REUTERS

Eloxx Q1 net loss widens to $3.75 million; operating loss widens to $3.8 million

Eloxx Pharmaceuticals sees Domicilium Real Estate Fund III LP file initial beneficial ownership statement

Eloxx Pharmaceuticals initial beneficial ownership statement names Coastlands Capital LP as 10% owner

Eloxx Pharma shareholders approve reverse stock split proposal

Eloxx Pharmaceuticals files draft information statement on equity plan, reverse split proposals

Kalaris CFO Matthew Gall resigns; Chief Accounting Officer Brett Hagen named principal financial officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ELOX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELOX\",,,,,undefined,":{"symbol":"ELOX","market":"US","secType":"STK","nameCN":"Eloxx Pharmaceuticals (Uplisting)","latestPrice":15.31,"timestamp":1790798400000,"preClose":15.42,"halted":0,"volume":14330,"delay":0,"changeRate":-0.0071335927367055406,"floatShares":2385600,"shares":4036314,"eps":-2.849267,"marketStatus":"Pre-Mkt","change":-0.11,"latestTime":"10-01 08:38:54 EDT","open":14.94,"high":15.71,"low":14.4201,"amount":217310.158165,"amplitude":0.083651,"askPrice":19.53,"askSize":100,"bidPrice":6.41,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.849267,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1780459200000,"exchange":"NASDAQ","adjPreClose":15.31,"postHourTrading":{"tag":"盘后","latestPrice":15.31,"preClose":15.31,"latestTime":"19:30 EDT","volume":13,"amount":199.03,"timestamp":1790811002004,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7218343547992147,"impliedVol":6.0667,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELOX\",,,,,undefined,":{"symbol":"ELOX","floatShares":2385600,"roa":"-97.59%","roe":"-615.23%","lyrEps":-5.340757,"volumeRatio":0.7218343547992147,"shares":4036314,"dividePrice":0,"high":15.71,"amplitude":0.083651,"preClose":15.42,"low":14.4201,"week52Low":0.000001,"pbRate":"1.33","week52High":23.3999,"institutionHeld":0.3674,"latestPrice":15.31,"eps":-2.849267,"divideRate":0,"volume":14330,"delay":0,"ttmEps":-2.849267,"open":14.94,"prevYearClose":0.0001,"prevWeekClose":15.03,"prevMonthClose":15.31,"prevQuarterClose":15.31,"fiveDayClose":15.435,"twentyDayClose":15.01,"sixtyDayClose":10.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"ELOX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-06-01","symbol":"ELOX","type":"split","dateTimestamp":1780286400000,"forFactor":11,"toFactor":1,"ratio":11},{"market":"US","date":"2023-08-14","symbol":"ELOX","fiscalQuarterEnding":"2023/06","expectedEps":-1.54,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1691985600000,"reportTimeType":"pre","actualEps":-1.96},{"market":"US","date":"2023-05-12","symbol":"ELOX","fiscalQuarterEnding":"2023/03","expectedEps":-2.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1683864000000,"reportTimeType":"post","actualEps":-5.2},{"market":"US","date":"2023-03-31","symbol":"ELOX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1680235200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELOX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1789790400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELOX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELOX","date":"2026-09-29","current":-5.373312,"percent":0.118761,"low":-9.628918,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"high":-0.092174,"avg":-1.371277,"sd":2.111874,"marketCap":60546885},"quantilePoints":[{"date":"2021-10-01","current":-2.413845,"twenty":-12.794427,"median":-4.826472,"eighty":-2.675371,"marketCap":138786443},{"date":"2021-10-08","current":-2.38386,"twenty":-12.794319,"median":-4.803231,"eighty":-2.661603,"marketCap":137062388},{"date":"2021-10-15","current":-2.293903,"twenty":-12.794319,"median":-4.776115,"eighty":-2.635904,"marketCap":131890222},{"date":"2021-10-22","current":-1.994046,"twenty":-12.791265,"median":-4.746127,"eighty":-2.622703,"marketCap":114649670},{"date":"2021-10-29","current":-2.054017,"twenty":-12.783349,"median":-4.710299,"eighty":-2.60043,"marketCap":118097781},{"date":"2021-11-05","current":-2.084003,"twenty":-12.714809,"median":-4.679277,"eighty":-2.572217,"marketCap":119821836},{"date":"2021-11-12","current":-1.760136,"twenty":-12.695947,"median":-4.668488,"eighty":-2.569857,"marketCap":106952926},{"date":"2021-11-19","current":-0.965236,"twenty":-12.695404,"median":-4.643802,"eighty":-2.555106,"marketCap":58651604},{"date":"2021-11-26","current":-0.979431,"twenty":-12.639315,"median":-4.632241,"eighty":-2.54298,"marketCap":59514128},{"date":"2021-12-03","current":-0.884185,"twenty":-12.595248,"median":-4.605034,"eighty":-2.52046,"marketCap":53726595},{"date":"2021-12-10","current":-1.047281,"twenty":-12.58847,"median":-4.547915,"eighty":-2.511737,"marketCap":63636991},{"date":"2021-12-17","current":-1.048559,"twenty":-12.586918,"median":-4.517225,"eighty":-2.506141,"marketCap":63714618},{"date":"2021-12-23","current":-1.06176,"twenty":-12.586918,"median":-4.503358,"eighty":-2.491076,"marketCap":64516765},{"date":"2021-12-31","current":-1.002426,"twenty":-12.580862,"median":-4.48781,"eighty":-2.473665,"marketCap":60911416},{"date":"2022-01-07","current":-0.886314,"twenty":-12.552759,"median":-4.38984,"eighty":-2.449828,"marketCap":53855973},{"date":"2022-01-14","current":-0.752458,"twenty":-12.520426,"median":-4.369517,"eighty":-2.434244,"marketCap":45722376},{"date":"2022-01-21","current":-0.638759,"twenty":-12.509782,"median":-4.349891,"eighty":-2.428838,"marketCap":38813562},{"date":"2022-01-28","current":-0.653805,"twenty":-12.485474,"median":-4.332407,"eighty":-2.418256,"marketCap":39727837},{"date":"2022-02-04","current":-0.649831,"twenty":-12.465228,"median":-4.307414,"eighty":-2.413845,"marketCap":39486330},{"date":"2022-02-11","current":-0.658632,"twenty":-12.456865,"median":-4.294294,"eighty":-2.385196,"marketCap":40021095},{"date":"2022-02-18","current":-0.66289,"twenty":-12.453398,"median":-4.287462,"eighty":-2.373405,"marketCap":40279852},{"date":"2022-02-25","current":-0.617609,"twenty":-12.44418,"median":-4.277444,"eighty":-2.368867,"marketCap":37528401},{"date":"2022-03-04","current":-0.567644,"twenty":-12.425856,"median":-4.229852,"eighty":-2.364555,"marketCap":34492318},{"date":"2022-03-11","current":-0.665445,"twenty":-12.153113,"median":-4.198617,"eighty":-2.353874,"marketCap":40435106},{"date":"2022-03-18","current":-0.646424,"twenty":-12.153113,"median":-4.17727,"eighty":-2.343818,"marketCap":39279324},{"date":"2022-03-25","current":-0.660335,"twenty":-12.145091,"median":-4.144153,"eighty":-2.338881,"marketCap":40124597},{"date":"2022-04-01","current":-0.758524,"twenty":-12.119775,"median":-4.127071,"eighty":-2.336233,"marketCap":50614064},{"date":"2022-04-08","current":-0.665543,"twenty":-12.048747,"median":-4.107148,"eighty":-2.308895,"marketCap":44409703},{"date":"2022-04-14","current":-0.587496,"twenty":-12.023142,"median":-4.087113,"eighty":-2.298307,"marketCap":39201853},{"date":"2022-04-22","current":-0.48049,"twenty":-11.953835,"median":-4.08537,"eighty":-2.293903,"marketCap":32061639},{"date":"2022-04-29","current":-0.437505,"twenty":-11.912503,"median":-4.085274,"eighty":-2.288459,"marketCap":29193422},{"date":"2022-05-06","current":-0.40681,"twenty":-11.827759,"median":-4.063065,"eighty":-2.277942,"marketCap":28335557},{"date":"2022-05-13","current":-0.382427,"twenty":-11.780007,"median":-4.055979,"eighty":-2.267157,"marketCap":26637156},{"date":"2022-05-20","current":-0.418007,"twenty":-11.68708,"median":-4.051511,"eighty":-2.258887,"marketCap":29115434},{"date":"2022-05-27","current":-0.367125,"twenty":-11.485224,"median":-4.047043,"eighty":-2.252796,"marketCap":25571323},{"date":"2022-06-03","current":-0.3879,"twenty":-11.394482,"median":-4.037026,"eighty":-2.245324,"marketCap":27018430},{"date":"2022-06-10","current":-0.37322,"twenty":-11.358128,"median":-4.016781,"eighty":-2.2256,"marketCap":25995924},{"date":"2022-06-17","current":-0.329678,"twenty":-11.31525,"median":-3.996956,"eighty":-2.207232,"marketCap":22963066},{"date":"2022-06-24","current":-0.297332,"twenty":-11.25073,"median":-3.967806,"eighty":-2.192328,"marketCap":20710086},{"date":"2022-07-01","current":-0.31139,"twenty":-11.188713,"median":-3.966904,"eighty":-2.184622,"marketCap":21689265},{"date":"2022-07-08","current":-0.367622,"twenty":-11.119884,"median":-3.961003,"eighty":-2.17396,"marketCap":25605985},{"date":"2022-07-15","current":-0.37322,"twenty":-10.858331,"median":-3.938415,"eighty":-2.163291,"marketCap":25995924},{"date":"2022-07-22","current":-0.39636,"twenty":-10.805441,"median":-3.936851,"eighty":-2.155145,"marketCap":27607671},{"date":"2022-07-29","current":-0.336147,"twenty":-10.770145,"median":-3.896782,"eighty":-2.121805,"marketCap":23413662},{"date":"2022-08-05","current":-0.366751,"twenty":-10.755706,"median":-3.873181,"eighty":-2.084003,"marketCap":25545327},{"date":"2022-08-12","current":-0.636991,"twenty":-10.742871,"median":-3.859983,"eighty":-2.05433,"marketCap":28163265},{"date":"2022-08-19","current":-0.842788,"twenty":-10.713992,"median":-3.843189,"eighty":-2.027031,"marketCap":37262166},{"date":"2022-08-26","current":-0.754785,"twenty":-10.692993,"median":-3.82085,"eighty":-2.009039,"marketCap":33371302},{"date":"2022-09-02","current":-0.692654,"twenty":-10.658873,"median":-3.807415,"eighty":-1.975892,"marketCap":30624301},{"date":"2022-09-09","current":-0.70363,"twenty":-10.653026,"median":-3.806625,"eighty":-1.971463,"marketCap":31109575},{"date":"2022-09-16","current":-0.439033,"twenty":-10.601559,"median":-3.792999,"eighty":-1.926634,"marketCap":19410988},{"date":"2022-09-23","current":-0.332607,"twenty":-10.596873,"median":-3.776573,"eighty":-1.853175,"marketCap":14705557},{"date":"2022-09-30","current":-0.333195,"twenty":-10.594246,"median":-3.768288,"eighty":-1.760136,"marketCap":14731554},{"date":"2022-10-07","current":-0.367691,"twenty":-10.588851,"median":-3.733422,"eighty":-1.703639,"marketCap":16256703},{"date":"2022-10-14","current":-0.313595,"twenty":-10.588851,"median":-3.705793,"eighty":-1.674968,"marketCap":13864992},{"date":"2022-10-21","current":-0.27224,"twenty":-10.476545,"median":-3.67139,"eighty":-1.624767,"marketCap":12036546},{"date":"2022-10-28","current":-0.313595,"twenty":-10.452479,"median":-3.646346,"eighty":-1.549839,"marketCap":13864992},{"date":"2022-11-04","current":-0.258912,"twenty":-10.372261,"median":-3.625005,"eighty":-1.254068,"marketCap":11447284},{"date":"2022-11-11","current":-0.233646,"twenty":-10.340173,"median":-3.616294,"eighty":-1.107183,"marketCap":9774819},{"date":"2022-11-18","current":-0.27818,"twenty":-10.332151,"median":-3.586241,"eighty":-1.055798,"marketCap":11637927},{"date":"2022-11-25","current":-0.291022,"twenty":-10.312899,"median":-3.579174,"eighty":-1.04589,"marketCap":12175196},{"date":"2022-12-02","current":-0.213865,"twenty":-10.300792,"median":-3.556189,"eighty":-1.028828,"marketCap":8947252},{"date":"2022-12-09","current":-0.147582,"twenty":-10.28701,"median":-3.528496,"eighty":-1.006741,"marketCap":6174254},{"date":"2022-12-16","current":-0.128423,"twenty":-10.264768,"median":-3.507027,"eighty":-0.97821,"marketCap":5372684},{"date":"2022-12-23","current":-0.105638,"twenty":-10.239098,"median":-3.454459,"eighty":-0.963192,"marketCap":4419466},{"date":"2022-12-30","current":-0.094246,"twenty":-10.185439,"median":-3.424421,"eighty":-0.936393,"marketCap":3942857},{"date":"2023-01-06","current":-0.238203,"twenty":-10.083474,"median":-3.364343,"eighty":-0.901701,"marketCap":9965463},{"date":"2023-01-13","current":-0.242346,"twenty":-9.911628,"median":-3.281736,"eighty":-0.879699,"marketCap":10138775},{"date":"2023-01-20","current":-0.203508,"twenty":-9.77887,"median":-3.221659,"eighty":-0.826677,"marketCap":8513971},{"date":"2023-01-27","current":-0.216454,"twenty":-9.586119,"median":-3.18411,"eighty":-0.775786,"marketCap":9055572},{"date":"2023-02-03","current":-0.221632,"twenty":-9.486599,"median":-3.161581,"eighty":-0.750417,"marketCap":9272213},{"date":"2023-02-10","current":-0.193152,"twenty":-9.359949,"median":-3.131543,"eighty":-0.740935,"marketCap":8080690},{"date":"2023-02-17","current":-0.201437,"twenty":-9.284497,"median":-3.091112,"eighty":-0.728004,"marketCap":8427315},{"date":"2023-02-24","current":-0.176063,"twenty":-9.24912,"median":-3.071465,"eighty":-0.715998,"marketCap":7365777},{"date":"2023-03-03","current":-0.164671,"twenty":-9.144917,"median":-3.0453,"eighty":-0.708075,"marketCap":6889167},{"date":"2023-03-10","current":-0.154682,"twenty":-9.039028,"median":-3.033917,"eighty":-0.694384,"marketCap":6471268},{"date":"2023-03-17","current":-0.175545,"twenty":-8.913723,"median":-3.00523,"eighty":-0.682365,"marketCap":7344112},{"date":"2023-03-24","current":-0.146547,"twenty":-8.822855,"median":-2.995213,"eighty":-0.666766,"marketCap":6130926},{"date":"2023-03-31","current":-0.129976,"twenty":-8.73217,"median":-2.969046,"eighty":-0.66289,"marketCap":5437676},{"date":"2023-04-06","current":-0.218008,"twenty":-8.657111,"median":-2.944997,"eighty":-0.657667,"marketCap":9120565},{"date":"2023-04-14","current":-0.495562,"twenty":-8.589396,"median":-2.928421,"eighty":-0.648079,"marketCap":17872437},{"date":"2023-04-21","current":-0.404258,"twenty":-8.506377,"median":-2.904829,"eighty":-0.632939,"marketCap":14579575},{"date":"2023-04-28","current":-0.433091,"twenty":-8.384678,"median":-2.892899,"eighty":-0.615839,"marketCap":15619426},{"date":"2023-05-05","current":-0.373023,"twenty":-8.061383,"median":-2.885021,"eighty":-0.605232,"marketCap":13453070},{"date":"2023-05-12","current":-0.245078,"twenty":-7.873737,"median":-2.875577,"eighty":-0.592703,"marketCap":8838732},{"date":"2023-05-19","current":-0.633487,"twenty":-7.772411,"median":-2.858254,"eighty":-0.586085,"marketCap":19432213},{"date":"2023-05-26","current":-0.543796,"twenty":-7.590076,"median":-2.854969,"eighty":-0.582389,"marketCap":16680941},{"date":"2023-06-02","current":-0.49436,"twenty":-7.475537,"median":-2.803659,"eighty":-0.566235,"marketCap":15164492},{"date":"2023-06-09","current":-0.432918,"twenty":-7.357659,"median":-2.764812,"eighty":-0.526282,"marketCap":13279762},{"date":"2023-06-16","current":-0.449161,"twenty":-7.259809,"median":-2.724582,"eighty":-0.496112,"marketCap":13778024},{"date":"2023-06-23","current":-0.293085,"twenty":-7.020927,"median":-2.700322,"eighty":-0.492382,"marketCap":8990377},{"date":"2023-06-30","current":-0.281079,"twenty":-6.953884,"median":-2.676365,"eighty":-0.473173,"marketCap":8622096},{"date":"2023-07-07","current":-0.254948,"twenty":-6.668597,"median":-2.668723,"eighty":-0.45192,"marketCap":7820545},{"date":"2023-07-14","current":-0.549446,"twenty":-6.447026,"median":-2.646775,"eighty":-0.444518,"marketCap":16854249},{"date":"2023-07-21","current":-0.470348,"twenty":-6.32866,"median":-2.621141,"eighty":-0.444518,"marketCap":14427930},{"date":"2023-07-28","current":-0.422325,"twenty":-6.233967,"median":-2.595294,"eighty":-0.443999,"marketCap":12954808},{"date":"2023-08-04","current":-0.459049,"twenty":-6.11336,"median":-2.571374,"eighty":-0.442099,"marketCap":14081314},{"date":"2023-08-11","current":-0.386307,"twenty":-5.878231,"median":-2.559436,"eighty":-0.439621,"marketCap":11849967},{"date":"2023-08-18","current":-0.520136,"twenty":-5.835033,"median":-2.535616,"eighty":-0.439033,"marketCap":12690288},{"date":"2023-08-25","current":-0.508854,"twenty":-5.699858,"median":-2.515038,"eighty":-0.439033,"marketCap":12415010},{"date":"2023-09-01","current":-0.603629,"twenty":-5.672493,"median":-2.508136,"eighty":-0.438727,"marketCap":14727340},{"date":"2023-09-08","current":-0.603629,"twenty":-5.556595,"median":-2.494476,"eighty":-0.438727,"marketCap":14727340},{"date":"2023-09-15","current":-0.612655,"twenty":-5.450502,"median":-2.47134,"eighty":-0.438727,"marketCap":14947562},{"date":"2023-09-22","current":-0.548343,"twenty":-5.357286,"median":-2.443831,"eighty":-0.438422,"marketCap":13378481},{"date":"2023-09-29","current":-0.580385,"twenty":-5.20793,"median":-2.433846,"eighty":-0.438116,"marketCap":14160225},{"date":"2023-10-04","current":-0.599188,"twenty":-5.195206,"median":-2.427255,"eighty":-0.438116,"marketCap":14618979},{"date":"2023-10-13","current":-0.50768,"twenty":-5.099417,"median":-2.413845,"eighty":-0.437453,"marketCap":12386374},{"date":"2026-06-12","current":-6.345648,"twenty":-1.075387,"median":-0.510857,"eighty":-0.281452,"marketCap":51019008},{"date":"2026-06-18","current":-7.028407,"twenty":-1.075387,"median":-0.510857,"eighty":-0.281452,"marketCap":56508396},{"date":"2026-06-26","current":-5.898842,"twenty":-1.063463,"median":-0.510603,"eighty":-0.281328,"marketCap":47426689},{"date":"2026-07-02","current":-6.074552,"twenty":-1.063463,"median":-0.510603,"eighty":-0.281328,"marketCap":48839399},{"date":"2026-07-10","current":-5.974146,"twenty":-1.063463,"median":-0.510603,"eighty":-0.281328,"marketCap":48032136},{"date":"2026-07-17","current":-6.03439,"twenty":-1.063463,"median":-0.510603,"eighty":-0.281328,"marketCap":48516494},{"date":"2026-07-24","current":-6.024349,"twenty":-1.063463,"median":-0.510603,"eighty":-0.281328,"marketCap":48435768},{"date":"2026-07-31","current":-6.676987,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":53682976},{"date":"2026-08-07","current":-8.890935,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":71483120},{"date":"2026-08-14","current":-7.227047,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":76975273},{"date":"2026-08-21","current":-6.836703,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":72817720},{"date":"2026-08-28","current":-6.063594,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":64583344},{"date":"2026-09-04","current":-5.37765,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":57277353},{"date":"2026-09-11","current":-6.169707,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":65713552},{"date":"2026-09-18","current":-6.651005,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":70839855},{"date":"2026-09-25","current":-6.063594,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":64583344},{"date":"2026-09-29","current":-5.68462,"twenty":-1.060568,"median":-0.509729,"eighty":-0.281203,"marketCap":60546885}],"updateTime":1790841841048},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELOX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652293628","title":"U.S. Research Roundup- Anterix, Fidus Investment, Nextpower","url":"https://stock-news.laohu8.com/highlight/detail?id=2652293628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652293628?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:39","pubTimestamp":1784533199,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Anterix, Fidus Investment, NextpowerJuly 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Anterix","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4N43M0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MWH","TRV","FRVO","IAT","ICLN","GE","ANTX","DFEN","ZAP","IAK","VZ","ROK","CMCSA","KNSL","ED","EXI","TMUS","VOX","KBWP","ES","AIG","T","TKR","KMT","NPO","BBIO","MNST","POOL","ITA","TFC","ATAI","ATEX","FE","BX","IPGP","RRX","PLNT","VCLN","RSI","PLMR","AEP","ENPH","FITB","NXT","BETZ","FDUS","CHTR","ELOX","KKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652731263","title":"Eloxx Pharmaceuticals initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2652731263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652731263?lang=en_us&edition=fundamental","pubTime":"2026-07-20 08:45","pubTimestamp":1784508305,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Eloxx Pharmaceuticals (ELOX) with a Buy rating and $43 price target Published first on TheFly – the ultimate sourc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650350973","title":"Eloxx Pharmaceuticals Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2650350973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650350973?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:20","pubTimestamp":1783610417,"startTime":"0","endTime":"0","summary":"11:17 EDT Eloxx Pharmaceuticals (ELOX) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQP","BK4007","ELOX","JULD","RSEE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897383","title":"NASDAQ Trade Halt Volatility Trading Pause at 11:17 Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897383","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650897383?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:17","pubTimestamp":1783610276,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 11:17 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nAQN2M7G9Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648547137","title":"Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2648547137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648547137?lang=en_us&edition=fundamental","pubTime":"2026-07-02 00:33","pubTimestamp":1782923591,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals ($ELOX) announced an update on their ongoing clinical study. Eloxx Pharmaceuticals, Inc. has launched the EXACT study, a Phas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eloxxs-exact-study-puts-exaluren-in-focus-for-rare-kidney-disease-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eloxxs-exact-study-puts-exaluren-in-focus-for-rare-kidney-disease-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4007","ISBC","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724453","title":"Eloxx Pharmaceuticals initial beneficial ownership filing names Domicilium Real Estate Fund III LP as 10% owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724453","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724453?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:11","pubTimestamp":1781730684,"startTime":"0","endTime":"0","summary":"Domicilium Real Estate Fund III LP filed a Form 3 disclosing a new 10% ownership position in Eloxx Pharmaceuticals .Reported indirect beneficial ownership of 14,285 common shares.Reported indirect holdings of pre-funded warrants for 2,407,384 common shares, exercisable at USD 0.11 per share.Form 3 was signed by Daniel Simon on June 17, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 17, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4LKPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","ELOXD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644454764","title":"Eloxx Pharmaceuticals Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2644454764","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644454764?lang=en_us&edition=fundamental","pubTime":"2026-06-17 02:20","pubTimestamp":1781634030,"startTime":"0","endTime":"0","summary":"14:19 EDT Eloxx Pharmaceuticals (ELOX) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644576443","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:19 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2644576443","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644576443?lang=en_us&edition=fundamental","pubTime":"2026-06-17 02:19","pubTimestamp":1781633993,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:19 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nAQN2M3S4Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642288320","title":"Eloxx Pharmaceuticals Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2642288320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642288320?lang=en_us&edition=fundamental","pubTime":"2026-06-11 17:06","pubTimestamp":1781168797,"startTime":"0","endTime":"0","summary":"09:30 EDT Eloxx Pharmaceuticals (ELOX) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eloxx-pharmaceuticals-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642041429","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642041429","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642041429?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:30","pubTimestamp":1781098222,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:30 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nAQN2M2VD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642846839","title":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642846839","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642846839?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:00","pubTimestamp":1780992002,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nAQN2M2NW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640559299","title":"Eloxx Pharmaceuticals files Form 3 for director Nina S. Kjellson, reporting no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2640559299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640559299?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:00","pubTimestamp":1780311639,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals director Nina S. Kjellson filed an initial Form 3 on May 27, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLchjM7X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634462336","title":"Eloxx Pharma shareholders back reverse stock split of up to 1-for-20","url":"https://stock-news.laohu8.com/highlight/detail?id=2634462336","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634462336?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:28","pubTimestamp":1778272111,"startTime":"0","endTime":"0","summary":"Board of Eloxx Pharmaceuticals unanimously adopted resolutions that were later ratified by majority shareholder written consent dated April 28, 2026.Capital actions authorized include reverse stock split of common stock within 1-for-2 to 1-for-20 range, with final ratio set by board any time before April 28, 2027.Certificate of incorporation amendment also authorizes cut in common stock authorized shares to 100,000,000 from 500,000,000, with timing set by board before April 28, 2027.Equity incentive changes adopted include raising 2018 plan share pool to 20,000,000 shares, extending plan evergreen feature, raising incentive stock option share limit to 80,000,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceutica","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL5nnMX4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633177300","title":"Eloxx Pharmaceuticals Inc - Applies to List Common Stock on Nasdaq Under Symbol Elox - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633177300","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633177300?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:58","pubTimestamp":1778187497,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633791695","title":"Eloxx Q1 net loss widens to $3.75 million; operating loss widens to $3.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633791695","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633791695?lang=en_us&edition=fundamental","pubTime":"2026-05-05 18:10","pubTimestamp":1777975826,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals posted a net loss of $3.75 million for quarter ended March 31, 2026, widening 120%.Operating loss widened to $3.8 million as total operating expenses climbed to $3.8 million, led by research and development expense of $1.66 million, up 225%.General and administrative expense rose to $2.14 million, up 200%, while other income swung to $41,000 from other expense.Cash and cash equivalents totaled $6.4 million at March 31, 2026; management said this is not sufficient to fund operations for at least the next 12 months, raising substantial doubt about going concern.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Ele","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLbvn0gL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633964047","title":"Eloxx Pharmaceuticals sees Domicilium Real Estate Fund III LP file initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633964047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633964047?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:26","pubTimestamp":1777933575,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals Form 3 filing shows Domicilium Real Estate Fund III LP reported as a 10% owner, with event date April 28, 2026.Indirect beneficial ownership reported for 1,407,138 common shares.Indirect holdings also include Pre-funded Warrant positions covering 22,214,434 common shares, exercisable at $0.01 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDLYhsJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632289629","title":"Eloxx Pharmaceuticals initial beneficial ownership statement names Coastlands Capital LP as 10% owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2632289629","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632289629?lang=en_us&edition=fundamental","pubTime":"2026-05-02 09:46","pubTimestamp":1777686361,"startTime":"0","endTime":"0","summary":"Coastlands Capital LP filed Form 3 reporting beneficial ownership in Eloxx Pharmaceuticals, marking 10% owner status as of April 27, 2026.Filing shows indirect ownership of 1,250,000 shares of common stock.It also reports 29,362,243 pre-funded warrants exercisable into common stock at USD 0.01 per share.Pre-funded warrants have no expiration date, with exercise subject to a 4.99% beneficial ownership cap.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260502:nNDL4BsHcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632095642","title":"Eloxx Pharma shareholders approve reverse stock split proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2632095642","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632095642?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:07","pubTimestamp":1777666075,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals shareholders acted April 28, 2026, backing amendments to 2018 Equity Incentive Plan.Consent ratified First Amendment raising share pool for awards to 20 million, raising incentive stock option share limit to 30 million.Holders also adopted amended and restated 2018 plan, extending period for granting incentive stock options, raising incentive stock option share limit, extending evergreen provision.Stockholders authorized reverse stock split at ratio between 1-for-2 to 1-for-20, leaving board to set exact ratio within one year.Approval also granted to cut authorized common shares to 100 million from 500 million, with timing set by board within one year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL1lpDk8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631531024","title":"Eloxx Pharmaceuticals files draft information statement on equity plan, reverse split proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2631531024","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631531024?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:38","pubTimestamp":1777412297,"startTime":"0","endTime":"0","summary":"Eloxx Pharmaceuticals shareholders authorized charter amendments for a reverse stock split of common stock at a ratio ranging from 1-for-2 to 1-for-20.Board received discretion to set split ratio, timing within 1 year of April 28, 2026 record date.Shareholders also authorized reduction in authorized common shares to 100,000,000 from 500,000,000.Restated 2018 plan lifted incentive stock option share limit to 80,000,000 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLrRLTS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626431110","title":"Kalaris CFO Matthew Gall resigns; Chief Accounting Officer Brett Hagen named principal financial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626431110","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626431110?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:02","pubTimestamp":1775851372,"startTime":"0","endTime":"0","summary":"Kalaris Therapeutics CFO Matthew Gall resigned effective April 14, 2026.Hagen has served as chief accounting officer since January 2019.He previously held finance and accounting leadership roles at Eloxx Pharmaceuticals, Proteostasis Therapeutics, and BIND Therapeutics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalaris Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL3Jn1Pq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","KLRS","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}